TipRanks
Go Ultimate55% OFF

Todd Davis Insider Profile

4 Followers

Todd Davis, CEO, Director at Ligand Pharma, holds 199.51K shares in Ligand Pharma (Ticker: LGND), holds 1.58M shares in Pelthos Therapeutics (Ticker: PTHS), holds 125.91K shares in Vaxart (Ticker: VXRT).

Todd Davis's Trading History

LGND
Ligand Pharma
Jul 06, 2026CEO, DirectorUninformative Buy21.21K$64.39M
PTHS
Pelthos Therapeutics
Jun 15, 2026DirectorInformative Buy999.82K$14.81M
VXRT
Vaxart
Aug 08, 2022DirectorUninformative Buy―$54.14K
BDSI
BioDelivery
Mar 22, 2022―Uninformative Sell―$0.00
PVLA
Palvella Therapeutics
―Director――

You May Also Like

Todd Davis insider profile FAQ

What is the percentage of profitable transactions made by Todd Davis?
The percentage of profitable transactions made by Todd Davis is 86%.
What is the average return per transaction made by Todd Davis?
The average return per transaction made by Todd Davis is 10.30%.
What stocks does Todd Davis hold?
Todd Davis holds: LGND, BDSI, PVLA, VXRT, PTHS stocks.
What was Todd Davis’s latest transaction?
Todd Davis’s latest transaction was an Uninformative Buy of $21.21K.
What was Todd Davis's most profitable transaction?
Todd Davis’s most profitable transaction was an Informative Buy of LGND stock on May 13, 2025. The return on the trade was 109.40%.
What is Todd Davis's role in Ligand Pharma?
Todd Davis's role in Ligand Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.